A Win For Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc. (GHSI:NASDAQ) soared at $8.38, representing a gain of 56.9%. On Wed, Jan 31, 2024, GHSI:NASDAQ touched a New 2-Week High of $8.38. The stock appeared on our News Catalysts scanner on Tue, Jan 30, 2024 at 08:59 PM in the 'AGREEMENT' category. From Wed, Jan 17, 2024, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Jan 31, 2024 at $10.75 with a volume of 11M+.
About Guardion Health Sciences, Inc. (GHSI:NASDAQ)
Guardion Health Sciences Inc is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Lumega-Z, is a micronized lipid-base nutritional formulation designed to restore and maintain the condition of a depleted macular pigment. It has also developed GlaucoCetin, the first regulated vision-specific Medical Food designed to support and protect the mitochondrial function of optic nerve cells in patients with glaucoma.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 212.5%
- Infobird Co. Ltd (IFBD:NASDAQ), 115.87%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 101.21%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 56.93%
- Earlyworks Co. Ltd. (ELWS:NASDAQ), 55.29%
- Powell Industries, Inc. (POWL:NASDAQ), 45.28%
- Momentus Inc. (MNTS:NASDAQ), 41.86%
- Electriq Power Holdings Inc. Class A (ELIQ:NYSE), 38.46%
- Trinity Biotech plc (TRIB:NASDAQ), 34.12%
- Nyxoah SA (NYXH:NASDAQ), 32.92%